Latest Breaking News On - European union medical device regulations - Page 3 : vimarsana.com

Hologic Announces Financial Results for Third Quarter of Fiscal 2023

– Revenue of $984.4 Million, GAAP Diluted EPS of , and Non-GAAP Diluted EPS of $0.93 – – Total Company Organic Revenue Growth excluding COVID-19 of 18.4% in constant currency Each Business.

United statesKarleen obertonSteve macmillanSkeletal healthHologic incAcessa healthDepartment of defenseInterventional breast solutionsEuropean union medical device regulationsBreast healthMolecular diagnosticsPanther fusionBlood screeningInvested capitalFourth quarterFull year fiscal

Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2023..

Robertb fordDrug administrationAbbott laboratoriesCore laboratoryAcelis connected healthCardiovascular systems incEuropean union medical device regulationsSystems incMedical devicesEstablished pharmaceuticalsAblation catheterSensor enabledCardiovascular systemsConsolidated statementPediatric nutritionAdult nutrition

Deadline Extended for Certain Medical Device Reforms

Deadline Extended for Certain Medical Device Reforms
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

European union medical device regulations

Form 20-F G Medical Innovations For: Dec 31

Form 20-F G Medical Innovations For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cayman islandsGreater accraMonte carloUnited statesGrand caymanLa pazTel avivGrand viewWhite houseDistrict of columbiaEquatorial guineaIsrael generalFrance generalHong kongWorld bankUnited kingdom

Hologic Announces Financial Results for Second Quarter of Fiscal 2023

– Revenue of $1,026.5 Million, GAAP Diluted EPS of $0.87, and Non-GAAP Diluted EPS of $1.06 All Exceed Guidance – – Total Company Organic Revenue Growth excluding COVID-19 Exceeds. | May 1, 2023

United statesKarleen obertonSteve macmillanAcessa healthDepartment of defenseOur breast healthHologic incInterventional breast solutionsEuropean union medical device regulationsSkeletal healthBreast healthMolecular diagnosticsBest midsize employersBlood screeningInvested capitalThird quarter